Recent Updates
Recently added Catalysts
MDAI Positive Sentiment Score: 70/100

Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

Key Takeaway: Spectral AI, Inc. will announce its financial results for the first quarter of 2025 on May 13, following a market close. The company, known for its AI-powered DeepView® System aimed at improving burn treatment outcomes, is hosting a conference call to discuss these results. This initiative underscores the company's focus on transparency and commitment to advancing medical diagnostics in wound care. As a forward-looking company, it acknowledges the inherent risks and uncertainties involved in its projections.

Market Sentiment Analysis

POSITIVE FACTORS

  • Spectral AI is set to report its first-quarter financial results, indicating transparency and communication with investors.
  • The DeepView® System has the potential to revolutionize wound care management and improve patient outcomes.
  • The company's innovative use of AI and multi-spectral imaging demonstrates a commitment to advancing medical diagnostics.

CONCERNS & RISKS

  • The article includes forward-looking statements that highlight uncertainties and risks in predicting future performance.
  • Readers are cautioned about relying on forward-looking statements due to various unknown factors affecting outcomes.

Full Press Release Details

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial results for the first quarter ended March 31, 2025 on Tuesday, May 13, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results.
Investors interested in participating in the live call can dial:
412-317-1837 - International
A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events.
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. The DeepView® System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView® System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView® System, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
For Media and Investor Relations, please contact:
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp

Tags

Frequently Asked Questions

When will Spectral AI report its Q1 2025 financial results?

Spectral AI will report its financial results on May 13, 2025.

What is the DeepView® System developed by Spectral AI?

The DeepView® System uses AI and multi-spectral imaging to assess burn wound healing potential.

How can investors participate in the Spectral AI conference call?

Investors can dial 412-317-1837 to join the live conference call.

What are the main goals of Spectral AI's DeepView® System?

The system aims to improve wound care management and enhance patient outcomes.

Where can I find more information about Spectral AI?

Visit Spectral AI's website at www.spectral-ai.com for more details.

Last updated: May 2, 2025